Jeffrey Kriegel, DPM
Podiatrist · Louisville, KYNPI 1114929098
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 34.1% of the total.
Across 16 payments — averaging $35.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$194
- Abbott$143
- Agile Therapeutics, Inc.$60
- Therapeuticsmd, Inc.$44
- Evofem Biosciences, Inc.$39
- Daiichi Sankyo Inc.$29
- plus $62 from 3 others
What the payments were for
- Food & beverage$570100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $194 |
| Abbott | 1 | $143 |
| Agile Therapeutics, Inc. | 3 | $60 |
| Therapeuticsmd, Inc. | 2 | $44 |
| Evofem Biosciences, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Avion Pharmaceuticals | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Supera peripheral stent system$143
- Santyl$125
- REGRANEX$125
- Oasis$125
How this compares
$570 in reported general payments places this provider in the 55th percentile of 54 podiatrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 26 | $96,439 |
| Ketoconazole | 508 | $20,696 |
| Clobetasol Propionate | 53 | $11,669 |
| Ammonium Lactate | 440 | $11,239 |
| Diclofenac Sodium | 72 | $7,492 |
| CiclopiroxCiclopirox Olamine | 114 | $7,058 |
| Ciclopirox | 158 | $4,579 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 26 | $3,877 |
| Lidocaine | 64 | $3,065 |
| Clotrimazole | 111 | $2,991 |
| Halobetasol Propionate | 33 | $2,860 |
| Caspofungin Acetate | 11 | $2,691 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 63 | $1,926 |
| Gabapentin | 66 | $1,092 |
| Triamcinolone Acetonide | 16 | $936 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Louisville
- Thomas ChildressLouisville$283K
- Joshua CogerLouisville$132K
- Zachery WeyandtLouisville$37K
- Andrew BouwkampLouisville$19K
- Braxton RiderLouisville$10K
- Ryan SherryLouisville$10K
- Walter PayneLouisville$10K
- Karim AshamLouisville$7K
- Peter CunninghamLouisville$6K
- Chirag PatelLouisville$179
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.